Corriente Advisors, LLC - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 33 filers reported holding DIAMEDICA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Corriente Advisors, LLC ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$906,000
-88.6%
203,641
-76.6%
0.49%
-83.3%
Q1 2021$7,963,000
-2.7%
870,228
+7.8%
2.93%
+50.5%
Q4 2020$8,182,000
+164.4%
806,900
+10.5%
1.95%
+24.2%
Q3 2020$3,095,000
+121.9%
730,000
+262.7%
1.57%
+73.6%
Q2 2020$1,395,000201,2480.90%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,197,245$2,993,0001.24%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 265,000$663,0000.40%
COOPERMAN LEON G 812,508$2,031,2700.11%
Ikarian Capital, LLC 221,252$553,0000.07%
Shay Capital LLC 10,000$25,0000.00%
Sandy Cove Advisors, LLC 1,200$3,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,603$52,0000.00%
Newbridge Financial Services Group, Inc. 1,269$3,0000.00%
Patriot Financial Group Insurance Agency, LLC 1,300$3,0000.00%
GROUP ONE TRADING, L.P. 20$00.00%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders